The coronavirus public health emergency has created new challenges for everyone, especially older adults and people with chronic health conditions. The Medicare
The Medicare Rights Center’s Annual Awards Event will be held virtually on October 19 at 6:00 PM. This year’s theme accurately depicts the organization and its partners since the coronavirus pandemic began: “Ready, Reliable, Resilient.” While Medicare Rights will miss seeing so many of its supporters in the ballroom, the organization is delighted that the online celebration will make it possible for many more to attend.
The Medicare Rights Center has a new president. The board of directors appointed Frederic Riccardi, vice president of client services,
It is with deep sorrow that we announce the passing of Cathy McElroy, our dedicated colleague and friend who worked tirelessly to further the Medicare Rights Center’s mission.
As Vice President of Operations for two decades, Cathy’s talents, compassion, and grace have been critical to our organization’s success. She touched the lives of those in the Medicare Rights community and many beyond it and will be forever missed.
Medicare Rights continues to support efforts and advance policies that make prescription drugs more affordable and do not otherwise increase costs or reduce access to care for older adults and people with disabilities.
This summer, Medicare Rights President Joe Baker was a panelist at a Capitol Hill briefing, “Tackling Prescription Drug Prices: An Examination of Proposed Medicare Part D Reforms,” an educational event hosted by the National Coalition on Health Care to shed light on proposed reforms to Medicare Part D, identify the trade-offs involved, and explore the impacts on people with Medicare.
The Medicare Rights federal policy team has been hard at work considering and responding to multiple U.S. Department of Health and Human Services (HHS) requests for comments on proposals regarding changes to Medicare Advantage plans and Part D as well as other regulatory and administrative issues such as Dual Eligible Special Needs Plans (D-SNPs) and Short-term, Limited Duration Insurance.
The Medicare Rights’ federal policy team’s work varies day to day, but their overall strategy leads to one goal: to protect and strengthen Medicare for the 56 million individuals who depend on the program today—and the many millions more who are counting on it for the years to come.
The Medicare Rights Center and over 30 other national and state organizations, including the Blue Cross Blue Shield Association and
Peter Bach, MD, MAPP, director of the Center for Health Policy and Outcomes at Memorial Sloan Kettering Cancer Center, was the guest speaker on “The Future of Drug Pricing” at the Medicare Rights Center’s Policy Breakfast on April 5.
Dr. Bach, a physician, epidemiologist, researcher, and healthcare policy expert whose work focuses on the cost and value of anticancer drugs, is an ardent supporter of value-based pricing for prescription drugs and favors the Centers for Medicare and Medicaid Services’ (CMS) recently announced proposal to test value-based payment strategies for medications covered under Medicare Part B.
The coronavirus public health emergency has created new challenges for everyone, especially older adults and people with chronic health conditions. The Medicare
The Medicare Rights Center’s Annual Awards Event will be held virtually on October 19 at 6:00 PM. This year’s theme accurately depicts the organization and its partners since the coronavirus pandemic began: “Ready, Reliable, Resilient.” While Medicare Rights will miss seeing so many of its supporters in the ballroom, the organization is delighted that the online celebration will make it possible for many more to attend.
The Medicare Rights Center has a new president. The board of directors appointed Frederic Riccardi, vice president of client services,
It is with deep sorrow that we announce the passing of Cathy McElroy, our dedicated colleague and friend who worked tirelessly to further the Medicare Rights Center’s mission.
As Vice President of Operations for two decades, Cathy’s talents, compassion, and grace have been critical to our organization’s success. She touched the lives of those in the Medicare Rights community and many beyond it and will be forever missed.
Medicare Rights continues to support efforts and advance policies that make prescription drugs more affordable and do not otherwise increase costs or reduce access to care for older adults and people with disabilities.
This summer, Medicare Rights President Joe Baker was a panelist at a Capitol Hill briefing, “Tackling Prescription Drug Prices: An Examination of Proposed Medicare Part D Reforms,” an educational event hosted by the National Coalition on Health Care to shed light on proposed reforms to Medicare Part D, identify the trade-offs involved, and explore the impacts on people with Medicare.
The Medicare Rights federal policy team has been hard at work considering and responding to multiple U.S. Department of Health and Human Services (HHS) requests for comments on proposals regarding changes to Medicare Advantage plans and Part D as well as other regulatory and administrative issues such as Dual Eligible Special Needs Plans (D-SNPs) and Short-term, Limited Duration Insurance.
The Medicare Rights’ federal policy team’s work varies day to day, but their overall strategy leads to one goal: to protect and strengthen Medicare for the 56 million individuals who depend on the program today—and the many millions more who are counting on it for the years to come.
The Medicare Rights Center and over 30 other national and state organizations, including the Blue Cross Blue Shield Association and
Peter Bach, MD, MAPP, director of the Center for Health Policy and Outcomes at Memorial Sloan Kettering Cancer Center, was the guest speaker on “The Future of Drug Pricing” at the Medicare Rights Center’s Policy Breakfast on April 5.
Dr. Bach, a physician, epidemiologist, researcher, and healthcare policy expert whose work focuses on the cost and value of anticancer drugs, is an ardent supporter of value-based pricing for prescription drugs and favors the Centers for Medicare and Medicaid Services’ (CMS) recently announced proposal to test value-based payment strategies for medications covered under Medicare Part B.
